Renal histologic changes and the outcome in patients with diabetic nephropathy

Nephrology Dialysis Transplantation

Volumn 30, Issue 2, 2015, Pages 257-266

  An, Yu ^a   Xu, Feng ^a   Le, Weibo ^a   Ge, Yongchun ^a   Zhou, Minlin ^a   Chen, Hao ^a   Zeng, Caihong ^a   Zhang, Haitao ^a   Liu, Zhihong ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

diabetes nephropathy; renal outcome; renal pathology

Indexed keywords

CREATININE;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE SEVERITY; END STAGE RENAL DISEASE; FEMALE; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OVERALL SURVIVAL; PROTEINURIA; SURVIVAL RATE; VASCULAR LESION; BIOPSY; BLOOD; GLOMERULUS; KIDNEY FUNCTION TEST; PATHOLOGY; PROGNOSIS; RISK FACTOR; SEVERITY OF ILLNESS INDEX; VASCULAR DISEASE;

BIOPSY; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY FUNCTION TESTS; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; PROGNOSIS; PROTEINURIA; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VASCULAR DISEASES;

EID: 84922509689     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu250     Document Type: Article

References (36)

1. Chan JC, Malik V, Jia Wet al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009; 301: 2129-2140
2. De Boer IH, Rue TC, Hall YN et al. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 2011; 305: 2532-2539
3. Wild S, Roglic G, Green A et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053
4. Liu ZH. Nephrology in china. Nat Rev Nephrol 2013; 9: 523-528
5. Oh SW, Kim S, Na KY et al. Clinical implications of pathologic diagnosis and classification for diabetic nephropathy. Diabetes Res Clin Pract 2012; 97: 418-424
6. Araki S, Haneda M, Sugimoto T et al. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes 2005; 54: 2983-2987
7. Gaede P, Tarnow L, Vedel P et al. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria. Nephrol Dial Transplant 2004; 19: 2784-2788
8. Perkins BA, Ficociello LH, Roshan B et al. In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney Int 2010; 77: 57-64
9. Jim B, Santos J, Spath F et al. Biomarkers of diabetic nephropathy, the present and the future. Curr Diabetes Rev 2012; 8: 317-328
10. McKillop AM, Flatt PR. Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine. Diabetes Care 2011; 34: 2624-2630
11. Niewczas MA, Gohda T, Skupien J et al. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol 2012; 23: 507-515
12. Titan SM, Zatz R, Graciolli FG et al. FGF-23 as a predictor of renal outcome in diabetic nephropathy. Clin J Am Soc Nephrol 2011; 6: 241-247
13. Fioretto P, Mauer M, Brocco E et al. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 1996; 39: 1569-1576
14. Gambara V, Mecca G, Remuzzi G et al. Heterogeneous nature of renal lesions in type II diabetes. J Am Soc Nephrol 1993; 3: 1458-1466
15. Mazzucco G, Bertani T, Fortunato M et al. Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies. Am J Kidney Dis 2002; 39: 713-720
16. Schwartz MM, Lewis EJ, Leonard-Martin T et al. Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group. Nephrol Dial Transplant 1998; 13: 2547-2552
17. Tervaert TW, Mooyaart AL, Amann K et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 2010; 21: 556-563
18. Fioretto P, Mauer M. Diabetic nephropathy: diabetic nephropathy-challenges in pathologic classification. Nat Rev Nephrol 2010; 6: 508-510
19. Okada T, Nagao T, Matsumoto H et al. Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria. Nephrology (Carlton) 2012; 17: 68-75
20. Caramori ML, Kim Y, Huang C et al. Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes 2002; 51: 506-513
21. Christensen PK, Larsen S, Horn T et al. Renal function and structure in albuminuric type 2 diabetic patients without retinopathy. Nephrol Dial Transplant 2001; 16: 2337-2347
22. Nosadini R, Velussi M, Brocco E et al. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes 2000; 49: 476-484
23. White KE, Bilous RW. Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease. J Am Soc Nephrol 2000; 11: 1667-1673
24. Heaf JG, Lokkegaard H, Larsen S. The relative prognosis of nodular and diffuse diabetic nephropathy. Scand J Urol Nephrol 2001; 35: 233-238
25. Hong D, Zheng T, Jia-qing S et al. Nodular glomerular lesion: a later stage of diabetic nephropathy?. Diabetes Res Clin Pract 2007; 78: 189-195
26. Shoji T, Kanda T, Nakamura H et al. Are glomerular lesions alternatives to microalbuminuria in predicting later progression of diabetic nephropathy?. Clin Nephrol 1996; 45: 367-371
27. Ruggenenti P, Gambara V, Perna A et al. The nephropathy of noninsulin-dependent diabetes: predictors of outcome relative to diverse patterns of renal injury. J Am Soc Nephrol 1998; 9: 2336-2343
28. Taft JL, Nolan CJ, Yeung SP et al. Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria. Diabetes 1994; 43: 1046-1051
29. Navarro-Gonzalez JF, Mora-Fernandez C, Muros De Fuentes M et al. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol 2011; 7: 327-340
30. Drummond K, Mauer M, International Diabetic Nephropathy Study G. The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes 2002; 51: 1580-1587
31. Kubo M, Kiyohara Y, Kato I et al. Risk factors for renal glomerular and vascular changes in an autopsy-based population survey: the Hisayama study. Kidney Int 2003; 63: 1508-1515
32. Harris RD, Steffes MW, Bilous RW et al. Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes. Kidney Int 1991; 40: 107-114
33. Fioretto P, Mauer M. Histopathology of diabetic nephropathy. Semin Nephrol 2007; 27: 195-207
34. Abbate M, Zoja C, Remuzzi G. How does proteinuria cause progressive renal damage?. J Am Soc Nephrol 2006; 17: 2974-2984
35. Tramonti G, Kanwar YS. Tubular biomarkers to assess progression of diabetic nephropathy. Kidney Int 2011; 79: 1042-1044
36. National Kidney F. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 update. Am J Kidney Dis 2012; 60: 850-886